SL

Sharianne L.

Senior Director at NiKang Therapeutics

Sharianne L. has worked in a variety of roles in the pharmaceutical and biotechnology industries since 1995. Her work experience includes a Staff Research Associate at Lawrence Berkeley National Laboratory (1995), Senior Research Associate at Pfizer (formerly SUGEN, Pharmacia Upjohn) (2000), Senior Research Specialist at Novartis (formerly Chiron) (2003), Senior Research Associate at Genentech - a Member of the Roche Group (2006), Pro Bono Marketing and Business Consultant at a Boutique Management Consulting Firm (2007), Associate Director at Celgene (2009) and Consultant for Lupus Research Alliance (2020). Most recently, they have been a Senior Director at NiKang Therapeutics Inc. (2021). During their tenure at Celgene, they provided project management support for the re-design of a new biospecimen management infrastructure and quality management system that grew the department from 15 to 40 employees and expanded office locations from 2 to 6 sites in 15 months.

Sharianne L. obtained their MBA from the University of California, Berkeley - Walter A. Haas School of Business, their MS in Endocrinology and Cancer Biology from the University of California, Berkeley - Graduate Group in Endocrinology and Cancer Biology, and their BS in Biochemistry from the University of California, Davis.

Location

San Francisco, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


NiKang Therapeutics

NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop first-in-class, and/or best-in-class small molecule targeted therapies and immuno-oncology (I-O) drugs to help cure cancers.


Industries

Employees

11-50

Links